Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value: $1.543B (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 16,064,461 | $260M | 16.8% | $7.04 | — | Common | 452907108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,189,524 | $106M | 6.9% | $86.12 | +1.0% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 7,263,122 | $105M | 6.8% | $8.69 | +58.1% | Common | 03152W109 |
| — | MIRATI THERAPEUTICS INC | 4,398,101 | $80.27M | 5.2% | $16.20 | — | Common | 60468T105 |
| — | CLOVIS ONCOLOGY INC | 1,102,884 | $75M | 4.9% | $75.87 | — | Common | 189464100 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 1,841,896 | $72.48M | 4.7% | $27.61 | — | Common | 37890U108 |
| — | ARRAY BIOPHARMA INC | 5,468,029 | $69.99M | 4.5% | $9.70 | — | Common | 04269X105 |
| ASND | ASCENDIS PHARMA | 1,681,024 | $67.34M | 4.4% | $28.93 | — | Sponsored ADR | 04351P101 |
| — | AVEXIS INC | 596,217 | $65.98M | 4.3% | $100.46 | — | Common | 05366U100 |
| — | HORIZON PHARMA PLC | 4,436,183 | $64.77M | 4.2% | $13.08 | — | Common | G4617B105 |
| ARGX | ARGENX SE | 804,875 | $50.82M | 3.3% | $41.13 | — | Sponsored ADR | 04016X101 |
| — | ZOGENIX INC | 1,263,313 | $50.6M | 3.3% | $35.99 | — | Common | 98978L204 |
| — | ASSEMBLY BIOSCIENCES INC | 1,068,534 | $48.35M | 3.1% | $26.73 | — | Common | 045396108 |
| — | DERMIRA INC | 1,520,000 | $42.27M | 2.7% | $29.94 | — | Common | 24983L104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 5,253,450 | $42.03M | 2.7% | $6.69 | +20.0% | Common | 462260100 |
| PCRX | PACIRA PHARMACEUTICALS INC | 848,572 | $38.74M | 2.5% | $41.43 | -4.3% | Common | 695127100 |
| — | MEDICINES CO | 1,296,560 | $35.45M | 2.3% | $44.69 | — | Common | 584688105 |
| BMY | BRISTOL MYERS SQUIBB CO | 456,223 | $27.96M | 1.8% | $46.46 | 0.0% | Common | 110122108 |
| TGTX | TG THERAPEUTICS INC | 3,294,463 | $27.02M | 1.8% | $8.74 | 0.0% | Common | 88322Q108 |
| AZN | ASTRAZENECA PLC | 750,300 | $26.04M | 1.7% | $34.70 | — | Sponsored ADR | 046353108 |
| VNDA | VANDA PHARMACEUTICALS INC | 1,408,946 | $21.42M | 1.4% | $13.89 | +6.9% | Common | 921659108 |
| — | TELIGENT INC | 5,049,431 | $18.33M | 1.2% | $7.54 | — | Common | 87960W104 |
| — | MYOKARDIA INC | 398,207 | $16.77M | 1.1% | $42.85 | — | Common | 62857M105 |
| CPRX | CATALYST PHARMACEUTICALS INC | 3,892,343 | $15.22M | 1.0% | $1.50 | +119.5% | Common | 14888U101 |
| — | INTEC PHARMA LTD | 2,195,705 | $11.31M | 0.7% | $8.95 | — | Common | M53644106 |
| — | AVEO PHARMACEUTICALS INC | 4,006,893 | $11.18M | 0.7% | $1.25 | — | Common | 053588109 |
| — | CASCADIAN THERAPEUTICS INC | 2,485,272 | $9.196M | 0.6% | $4.09 | — | Common | 14740B606 |
| — | ALIMERA SCIENCES INC | 6,241,581 | $8.301M | 0.5% | $1.43 | — | Common | 016259103 |
| — | IMMUNOMEDICS INC | 875,000 | $8.225M | 0.5% | $7.04 | — | Call | 452907108 |
| — | AGENUS INC | 2,439,554 | $7.953M | 0.5% | $4.72 | — | Common | 00847G705 |
| APLS | APELLIS PHARMACEUTICALS INC | 396,635 | $7.316M | 0.5% | $14.72 | 0.0% | Common | 03753U106 |
| — | BIODELIVERY SCIENCE INTL | 2,469,488 | $7.285M | 0.5% | $2.95 | — | Common | 09060J106 |
| — | NEWLINK GENETICS CORP | 795,412 | $6.451M | 0.4% | $8.11 | — | Common | 651511107 |
| VRAYQ | VIEWRAY INC | 730,161 | $5.824M | 0.4% | $8.00 | 0.0% | Common | 92672L107 |
| — | CATALYST BIOSCIENCES INC | 400,000 | $5.456M | 0.4% | $13.64 | — | Common | 14888D208 |
| — | VIVEVE MEDICAL INC | 1,033,276 | $5.135M | 0.3% | $6.08 | — | Common | 92852W204 |
| VCYT | VERACYTE INC | 752,455 | $4.914M | 0.3% | $8.90 | -16.4% | Common | 92337F107 |
| INCY | INCYTE CORP | 50,000 | $4.736M | 0.3% | $104.52 | 0.0% | Common | 45337C102 |
| FENC | FENNEC PHARMACEUTICALS INC | 206,000 | $2.726M | 0.2% | $10.48 | -4.8% | Common | 31447P100 |
| — | PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | $2.53M | 0.2% | $0.21 | — | Convertible Debt | 71426VAK4 |
| CLLS | CELLECTIS S A | 78,289 | $2.282M | 0.1% | $24.12 | — | Sponsored ADS | 15117K103 |
| FOLD | AMICUS THERAPEUTICS INC | 1,500,000 | $1.763M | 0.1% | $8.69 | +58.1% | Call | 03152W109 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 340,821 | $1.673M | 0.1% | $4.52 | +7.1% | Common | 09058V103 |
| — | ONCOBIOLOGICS INC | 683,531 | $889K | 0.1% | $3.27 | — | Common | 68235M105 |
| — | CLOVIS ONCOLOGY INC | 675,000 | $264K | 0.0% | $75.87 | — | Call | 189464100 |
| — | ARRAY BIOPHARMA INC | 75,000 | $216K | 0.0% | $9.70 | — | Call | 04269X105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 300,000 | $135K | 0.0% | $86.12 | +1.0% | Call | 09061G101 |
| MGNX | MACROGENICS INC | 14,500 | $37,000 | 0.0% | — | — | Call | 556099109 |
| — | ONCOBIOLOGICS INC - WARRANT A | 233,333 | $7,000 | 0.0% | $0.46 | — | Warrant | 68235M113 |
| — | ONCOBIOLOGICS INC - WARRANT B | 233,333 | $5,000 | 0.0% | $0.45 | — | Warrant | 68235M121 |